Publications
Johanna Joyce Lab publications
Selected Publications
Click on the links below or see all Joyce lab and collaborative publications on Europe PMC.
Watson SS, Duc B, Kang Z, de Tonnac A, Eling N, Font L, Whitmarsh T, Massara M, IMAXT Consortium, Bodenmiller B, Hausser J, and Joyce JA (2024). Microenvironmental reorganisation in brain tumors following radiotherapy and recurrence revealed by hyperplexed immunofluorescence imaging (HIFI). Nature Communications, 15(1):3226, doi: 10.1038/s41467-024-47185-9.
Joyce JA (2024). How I made my lab meetings more inclusive with a rapid-relay technique. Commissioned ‘Careers feature’ for Nature. Joyce JA (2024). Trans-Atlantic twists and turns. Invited perspective for Nature Cancer 5: 693-694.
Joyce JA, Masina S, Michalik L, Pot C, Sempoux C, Amati F (2024). Closing the scissor-shaped curve: strategies to promote gender equality in academia. Cell 187: 1335-1342.
Bejarano L, Kauzlaric A, Lamprou E, Lourenco J, Fournier N, Ballabio M, Colotti R, Maas RR, Massara M, Soukup K, Lilja J, Brouland J-P, Hottinger AF, Daniel RT, Hegi ME, and Joyce JA (2024). Interrogation of endothelial and mural cells in brain metastasis reveals key immune-regulatory mechanisms. Cancer Cell 42: 378-395.
Massara M, Dolfi B, Wischnewski V, Nolan E, Held W, Malanchi I, and Joyce JA (2024). Investigation of a fluorescent reporter microenvironment niche labeling strategy in experimental brain metastasis. iScience 27: 110284.
Maas RR, Soukup K, Fournier N, Massara M, Galland S, Kornete M, Wischnewski V, Lourenco J, Croci D, Álvarez-Prado AF, Marie DN, Lilja J, Marcone R, Fernandez Calvo G, Santalla Mendez R, Aubel P, Bejarano L, Wirapati P, Ballasteros I, Hidalgo A, Hottinger AF, Brouland J-P, Daniel RT, Hegi ME, and Joyce JA (2023). The local microenvironment drives activation of neutrophils in human brain tumors. Cell 186: 4546-4566.
Wischnewski V, Maas RR, Aruffo PG, Soukup K, Galletti G, Kornete M, Galland S, Fournier N, Lilja J, Wirapati P, Lourenco J, Scarpa A, Daniel RT, Hottinger AF, Brouland J-P, Losurdo A, Voulaz E, Alloiso M, Hegi ME, Lugli E, and Joyce JA (2023). Phenotypic diversity of T cells in primary and metastatic brain tumors revealed by multiomic interrogation. Nature Cancer 4: 908–924.
Theis FJ, Dar D, Vento-Tormo R, Vicković S, Wang L, Kagohara LT, Rendeiro AF, and Joyce JA (2023). What do you most hope spatial molecular profiling will help us understand? Cell Systems 14: 423-427.
de Visser K and Joyce JA (2023). The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41: 374-403.
Qian BZ and Joyce JA (2023). Obituary for Jeffrey W. Pollard (1950–2023). Immunity 56: 1153-1154.
Loi S, Settleman J, Joyce JA, Pramesh CS, Bernards R, Fan J, Merchant JL, Moslehi J, Sellers WR (2023). The next big questions in cancer research. Cell 186:1523-1527.
Croci D*, Zomer A*, Kowal J, and Joyce JA (2023). Cranial imaging window implantation technique for longitudinal multimodal imaging of the brain environment in live mice. STAR Protocols 4: 102197.
Álvarez-Prado ÁF, Maas RR, Soukup K, Klemm F, Kornete M, Krebs FS, Zoete V, Berezowska S, Brouland J-P, Hottinger AF, Daniel RT, Hegi ME, Joyce JA (2023). Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors. Cell Reports Medicine 4:100900, doi: 10.1016/j.xcrm.2022.100900 Croci D, Santalla Mendez R, Temme S, Soukup K, Fournier N, Zomer A, Colotti R, Wischnewski V, Flögel U, van Heeswijk R, and Joyce JA (2022). Longitudinal and non-invasive monitoring of the spatial and temporal dynamics of glioma-associated macrophages. Science Translational Medicine 14: eabo2952, doi: 10.1126/scitranslmed.abo2952
Chryplewicz A, Scotton J, Tichet M, Zomer A, Shchors K, Joyce JA, Homicsko K, and Hanahan D (2022). Immunogenic autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity. Cancer Cell 40:1111-1127.
Zomer A*, Croci D*, Kowal J, van Gurp L, and Joyce JA (2022). Multimodal imaging of the dynamic brain tumor microenvironment during glioblastoma progression and in response to treatment. iScience 25: 104570.
Bejarano L*, Jordao MC* and Joyce JA (2021). Therapeutic targeting of the tumor microenvironment. Cancer Discovery 11: 933-959.
Maas RR*, Soukup K*, Klemm F*, Kornete M, Bowman RL, Bedel R, Marie DN, Alvarez-Prado AF, Labes D, Wilson A, Brouland JP, Daniel RT, Hegi ME, and Joyce JA (2021). An integrated pipeline for the comprehensive analysis of immune cells in human brain tumour clinical samples. Nature Protocols 16: 4692-4721.
Klemm F, Möckl A, Salamero-Boix A, Alekseeva T, Schäffer A, Schulz M, Niesel K, Maas RR, Groth M, Elie BT, Bowman RL, Hegi ME, Daniel RT, Zeiner PS, Zinke J, Harter PN, Plate KH, Joyce JA# and Sevenich L# (2021). Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R Inhibition in breast-to-brain metastasis. (# Joint corresponding authors). Nature Cancer 2: 1086-1101 Klemm F, Maas RR, Bowman RL, Kornete M, Soukup K, Nassiri S, Brouland JP, Iacobuzio-Donahue CA, Brennan C, Tabar V, Gutin PH, Daniel RT, Hegi ME, and Joyce JA (2020). Interrogation of the microenvironmental landscape in brain tumors reveals disease-specific alterations of immune cells. Cell 181(7):1643-1660.
Akkari L#, Bowman RL, Tessier J, Klemm F, Handgraaf S, de Groot M, Quail DF, Tillard L, Gadiot J, Huse JT, Brandsma D, Westerga J, Watts C, and Joyce JA# (2020). Dynamic changes in glioma macrophage populations after radiotherapy reveals CSF-1R inhibition as a strategy to overcome resistance. (# Corresponding authors). Science Translational Medicine 12(552):eaaw7843, doi: 10.1126/scitranslmed.aaw7843.
Valiente M, Van Swearingen AED, Anders CK, Bairoch A, Boire A, Bos PD, Cittelly DM, Erez N, Ferraro GB, Fukumura D, Gril B, Herlyn M, Holmen SL, Jain RK, Joyce JA, Lorger M, Massague J, Neman J, Sibson NR, Steeg PS, Thorsen F, Young LS, Varešlija D, Vultur A, Weis-Garcia F, and Winkler F (2020). Brain metastasis cell lines panel: a public resource of organotropic cell lines. Cancer Research 80: 4314-4323.
Bernards R, Jaffee E, Joyce JA, Lowe SW, Mardis ER, Morrison SJ, Polyak K, Sears CL, Vousden KH, Zhang Z (2020). A roadmap for the next decade in cancer research. Nature Cancer 1: 12-17.
Kowal J, Kornete M, and Joyce JA (2019). Re-education of macrophages as a therapeutic strategy in cancer. Immunotherapy 11: 677-689.
Aldape K, Brindle KM, Chesler L, Chopra R, Hajjar A, Gilbert MR, Gottardo N, Gutmann DH, Hargrave D, Holland EC, Jones DTW, Joyce JA, Kearns P, Kieran MW, Mellinghoff IK, Merchant M, Pfister SM, Pollard SM, Ramaswamy V, Rich JN, Robinson GW, Rowitch DH, Sampson JH, Taylor MD, Workman P, and Gilbertson RJ (2019). Challenges to curing primary brain tumors. Nature Reviews Clinical Oncology 16: 509-520.
Soukup K and Joyce JA (2018). A long-distance relay-tionship between tumor and bone. Immunity 48: 13-16.
Olson OC, Quail DF, and Joyce JA (2017). Obesity and the tumor microenvironment. Science 358: 1130-31.
Quail DF*, Olson OC*, Bhardwaj P, Walsh LA, Akkari L, Quick ML, Chen IC, Wendel N, Ben-Chetrit N, Walker J, Holt PR, Dannenberg AJ, and Joyce JA (2017). Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF. Nature Cell Biology 19:974-987.
Yan D, Kowal J, Akkari L, Schuhmacher AJ, Huse JT, West BL, and Joyce JA (2017). Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas. Oncogene 36: 6049-6058.
Olson OC, Kim H, Quail DF, Foley EA, and Joyce JA (2017). Tumor-associated macrophages suppress the cytotoxic activity of antimitotic agents. Cell Reports 19:101-113.
Quail DF and Joyce JA (2017). The microenvironmental landscape of brain tumors. Cancer Cell 31:326-341
Quail DF and Joyce JA (2017). Molecular pathways: dissecting mechanisms of resistance to macrophage-targeted therapies. Clinical Cancer Research 23: 876-884.
Bowman RL, Klemm F, Akkari L, Pyonteck SM, Sevenich L, Quail DF, Dhara S, Simpson K, Gardner EE, Iacobuzio-Donahue C, Brennan CW, Tabar V, Gutin PH, and Joyce JA (2016). Macrophage ontogeny underlies differences in tumor-specific education in brain malignancies. Cell Reports 17: 2445-2459.
Yan D*, Wang H*, Bowman RL*, and Joyce JA (2016). STAT3 and STAT6 signaling pathways synergize to promote cathepsin secretion from macrophages via IRE1α activation. Cell Reports 16: 2914–2927.
Prudova A*, Gocheva V*, Auf dem Keller U*, Eckhard U*, Olson OC, Akkari L, Butler GS, Fortelny N, Lange PF, Mark JC, Joyce JA# and Overall CM# (2016). TAILS N-terminomics and proteomics show protein degradation dominates over proteolytic processing by cathepsins in pancreatic tumors. (# Joint senior authors). Cell Reports 16: 1762-1773.
Quail DF, Bowman RL, Akkari L, Quick ML, Schuhmacher AJ, Huse JT, Holland EC, Sutton JC, and Joyce JA (2016). The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas. Science 352: 6288
Akkari L and Joyce JA (2016). Microenvironmental InterFereNce of metabolism regulates chemosensitivity. Cell Research 26: 867-8.
Mason SD and Joyce JA (2011). Proteolytic networks in cancer. Trends in Cell Biology 21: 228-237. Mason SD and Joyce JA (2011). Proteolytic cascades in invasion and metastasis. Cancer Metastasis: Biologic Basis and Therapeutics. Cambridge University Press. Editors: Lyden DC, Welsh DR, Psaila B. Joyce JA (2005). Therapeutic targeting of the tumor microenvironment. Cancer Cell 6: 513-520.